19 results match your criteria: "Queen Elizabeth Hospitals[Affiliation]"
Heart Lung Circ
September 2024
Department of Cardiology, Royal Adelaide Hospital and The Queen Elizabeth Hospital, Adelaide, SA, Australia; University of Adelaide, Basil Hetzel Institute, Adelaide, SA, Australia.
Background: Functional coronary angiography (FCA) for endotype characterisation (vasospastic angina [VSA], coronary microvascular disease [CMD], or mixed) is recommended among patients with angina with non-obstructive coronary arteries. Whilst clear diagnostic criteria for VSA and CMD exist, there is no standardised FCA protocol. Variations in testing protocol may limit the widespread uptake of testing, generalisability of results, and expansion of collaborative research.
View Article and Find Full Text PDFAust Prescr
December 2022
Royal Adelaide and The Queen Elizabeth Hospitals, Central Adelaide Local Health Service, South Australia.
Cardiovascular disease is the leading global cause of death in women but remains underdiagnosed and undertreated. Health professionals play an important role in improving the heart health of Australian women. Routine heart health checks should be offered to all women 45 years of age and older and to all Aboriginal and Torres Strait Islander women 30 years of age and older.
View Article and Find Full Text PDFBMC Med Inform Decis Mak
May 2022
HDR-UK Midlands Site and Better Care Programme, Queen Elizabeth Hospitals NHS Foundation Trust, Mindlesohn Way, Edgbaston, Birmingham, B15 2WB, UK.
Background: Venous thromboembolism (VTE) causes significant mortality and morbidity in hospitalised patients. Risk factors for VTE are well known and there are validated risk assessment tools to support the use of prophylactic therapies. In England, reporting the percentage of patients with a completed VTE risk assessment is mandated, but this does not include whether that risk assessment resulted in appropriate prescribing.
View Article and Find Full Text PDFBMJ Open
September 2021
Department of Surgery, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Introduction: Diabetic foot disease is a common condition globally and is over-represented in indigenous populations. The propensity for patients with diabetic foot disease to undergo minor or major limb amputation is a concern. Diabetic foot disease and lower limb amputation are debilitating for patients and have a substantial financial impact on health services.
View Article and Find Full Text PDFTransplantation
March 2020
Renal Unit, University Hospitals Coventry & Warwickshire NHS Trust, Coventry, United Kingdom.
Background: Understanding the outcomes and risks for live kidney donors (LD) is increasingly important; this study investigated all-cause mortality and morbidity outcomes of LD compared with a healthy cohort.
Methods: Live donor dataset was obtained from the UK Transplant Registry and a comparator nondonor cohort selected from The Health Improvement Network (THIN) database, a UK primary healthcare database. All LD from January 1, 2001, to December 31, 2013, were included, with follow-up until December 31, 2016.
Am J Med Genet A
October 2019
Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.
Zinc finger protein 462 (ZNF462) is a relatively newly discovered vertebrate specific protein with known critical roles in embryonic development in animal models. Two case reports and a case series study have described the phenotype of 10 individuals with ZNF462 loss of function variants. Herein, we present 14 new individuals with loss of function variants to the previous studies to delineate the syndrome of loss of function in ZNF462.
View Article and Find Full Text PDFNatural killer cells are thought to influence the outcome of hematopoietic stem cell transplant (HSCT), impacting on relapse, overall survival, graft versus host disease and the control of infection, in part through the complex interplay between the large and genetically diverse killer immunoglobulin-like receptor (KIR) family and their ligands. This study examined the relationship between KIR gene content and clinical outcomes including the control of opportunistic infections such as cytomegalovirus in the setting of human leucocyte antigen (HLA)-matched sibling HSCT in an Australian cohort. The presence of the KIR B haplotype which contain more activating receptors in the donor, in particular centromeric B haplotype genes (Cen-B), was associated with improved overall survival of patients with acute myeloid leukemia (AML) undergoing sibling HSCT and receiving myeloablative conditioning.
View Article and Find Full Text PDFClin Dysmorphol
October 2017
aDevelopmental Endocrinology Research Group, Child Health, School of Medicine, University of Glasgow, Royal Hospital for Children bWest of Scotland Genetics Service, Laboratory Medicine Building, Queen Elizabeth Hospitals, Glasgow cSheffield Diagnostics Genetics Service, Sheffield Children's NHS Foundation Trust, Western Bank, Sheffield, UK.
Am J Hum Genet
July 2017
Division of Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address:
We report 15 individuals with de novo pathogenic variants in WDR26. Eleven of the individuals carry loss-of-function mutations, and four harbor missense substitutions. These 15 individuals comprise ten females and five males, and all have intellectual disability with delayed speech, a history of febrile and/or non-febrile seizures, and a wide-based, spastic, and/or stiff-legged gait.
View Article and Find Full Text PDFInt Anesthesiol Clin
February 2019
*Department of Military Anaesthesia and Critical Care, Royal Centre for Defence Medicine, Birmingham, UK †Department of Anaesthesia, Aintree University Hospital NHS Foundation Trust, Liverpool, UK ‡Department of Anaesthesia, Queen Elizabeth Hospitals, Birmingham, UK. §Military Anaesthesia, Academic Department of Military Anaesthesia, Royal Centre for Defence Medicine, Birmingham, UK ∥Department of Anaesthesia, Derriford Hospital, Plymouth Hospitals NHS Trust, Plymouth, UK.
Thromb J
December 2014
Department of Haematology, SA Pathology, Royal Adelaide and Queen Elizabeth Hospitals, Frome Rd, Adelaide, SA 5000 Australia.
Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism, is a common condition associated with a significant clinical and economic burden. Anticoagulant therapy is the mainstay of treatment for VTE, having been shown to reduce the risk of death in patients with pulmonary embolism, and recurrence or extension of thrombi in patients with deep vein thrombosis during the initial treatment period. Long-term anticoagulation is indicated in some individuals with VTE, depending on individual risk of VTE recurrence and anticoagulant-related bleeding.
View Article and Find Full Text PDFAnn R Coll Surg Engl
April 2012
Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospitals, Edgbaston, Birmingham, UK.
Rheumatology (Oxford)
September 2011
Department of Rheumatology, Selly Oak and Queen Elizabeth Hospitals Birmingham, University Hospital Birmingham NHS Foundation Trust, Oak Tree Lane Offices, Selly Oak, Birmingham, UK.
Modelling cost-effectiveness of new drugs for RA has become increasingly prevalent and sophisticated. This situation has arisen largely because regulatory agencies, such as the National Institute for Health and Clinical Excellence, have demanded models from industry and have commissioned independent models. Many technical aspects of health economic models have converged-yet the results of models differ greatly.
View Article and Find Full Text PDFInt J Pediatr Otorhinolaryngol
December 2003
Paediatric Infectious Diseases Unit, Newcastle General and Queen Elizabeth Hospitals, Tyne & Wear, 26A Heddon Banks, Heddon-on-the-Wall, Northumberland NE15 0BU, UK.
The global epidemic of HIV infection remains appalling. By 2001, there were an estimated 1.4 million HIV-infected children, with 4.
View Article and Find Full Text PDFInt J Gynecol Cancer
May 2000
Departments of Gynaecological Oncology and Radiation Oncology, Royal Adelaide and Queen Elizabeth Hospitals, Adelaide, South Australia, Australia.
A retrospective review of side effects and complications of treatment in 522 patients with endometrial cancer managed in a gyneoncology unit was conducted. This study evaluated 517 patients who underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH BSO). Lymphadendectomy or lymph node sampling was performed with the primary surgery in 264 and 41 cases, respectively.
View Article and Find Full Text PDFJ Clin Endocrinol Metab
July 1999
Queen Elizabeth Hospitals, Birmingham, United Kingdom.
Case-control studies suggest that the CTLA-4 gene may be a susceptibility locus for Graves' disease. The previously reported A/G polymorphism at position 49 in exon 1 of the CTLA-4 gene was, therefore, investigated in a case-control (n = 743) and family-based (n = 179) dataset of white Caucasian subjects with Graves' disease. The relationship between CTLA-4 genotype and severity of thyroid dysfunction at diagnosis was also investigated.
View Article and Find Full Text PDFJ Wound Care
July 1992
Clinical nurse specialist in tissue viability at Moseley Hall and Queen Elizabeth Hospitals, Birmingham.
An assessment of a trial of a protective skin wipe for patients with a reaction to adhesive tapes.
View Article and Find Full Text PDFBr J Neurosurg
November 1989
Department of Neurosurgery, Queen Elizabeth Hospitals, Birmingham, United Kingdom.
With an incidence of approximately 1 in 2,000 per head of population, most neurosurgeons are presented at times with the problem of craniosynostosis. This paper summarises the different clinical effects of different skull deformities, and describes the present state of the art with regard to surgical management.
View Article and Find Full Text PDFJ Rheumatol
October 1987
Queen Elizabeth Hospitals Rheumatology Unit, Adelaide, South Australia.
The antiinflammatory agent piroxicam caused dose dependent inhibition of N-formylmethionyl-leucyl-phenylalanine (FMLP) induced monocyte superoxide release in vitro, but had no effect on the response to serum treated zymosan, phorbol myristate acetate or the calcium ionophore A23187. The inhibitory effect on the superoxide response to FMLP correlated with inhibition of specific 3H-FMLP binding. Piroxicam did not inhibit production of leukotriene B4 stimulated either by A23187 or by FMLP with arachidonic acid.
View Article and Find Full Text PDF